Pathophysiology of Non Alcoholic Fatty Liver Disease

The physiopathology of fatty liver and metabolic syndrome are influenced by diet, life style and inflammation, which have a major impact on the severity of the clinicopathologic outcome of non-alcoholic fatty liver disease. A short comprehensive review is provided on current knowledge of the pathophysiological interplay among major circulating effectors/mediators of fatty liver, such as circulating lipids, mediators released by adipose, muscle and liver tissues and pancreatic and gut hormones in relation to diet, exercise and inflammation.

[1]  J. Holst,et al.  The biology of glucagon and the consequences of hyperglucagonemia. , 2016, Biomarkers in medicine.

[2]  S. Klein,et al.  VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women. , 2016, The Journal of clinical endocrinology and metabolism.

[3]  F. Shamoun,et al.  Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque. , 2016, European heart journal.

[4]  P. Scherer.  The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and Beyond: The 2015 Banting Lecture , 2016, Diabetes.

[5]  M. Orešič,et al.  Ceramides Dissociate Steatosis and Insulin Resistance in the Human Liver in Non-Alcoholic Fatty Liver Disease Short title : Ceramides in Human Non-Alcoholic Fatty Liver Disease , 2016 .

[6]  C. Mantzoros,et al.  Diet quality and diet patterns in relation to circulating cardiometabolic biomarkers. , 2016, Clinical nutrition.

[7]  A. Fornoni,et al.  Systemic and renal lipids in kidney disease development and progression. , 2016, American journal of physiology. Renal physiology.

[8]  Mikael Fogelholm,et al.  Associations of egg and cholesterol intakes with carotid intima-media thickness and risk of incident coronary artery disease according to apolipoprotein E phenotype in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2016, The American journal of clinical nutrition.

[9]  Rachel M. Brown,et al.  Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study , 2016, The Lancet.

[10]  E. Ruppin,et al.  Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease , 2016, Nature Communications.

[11]  G. Ioannou.  The Role of Cholesterol in the Pathogenesis of NASH , 2016, Trends in Endocrinology & Metabolism.

[12]  G. Marchesini,et al.  Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD? , 2016, Journal of hepatology.

[13]  S. Doǧru-Abbasoǧlu,et al.  The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet , 2016, Archives of physiology and biochemistry.

[14]  T. Vilsbøll,et al.  Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia , 2016, Journal of internal medicine.

[15]  J. Bressan,et al.  Saturated fatty acids trigger TLR4-mediated inflammatory response. , 2016, Atherosclerosis.

[16]  S. Gorgani-Firuzjaee,et al.  Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. , 2016, Translational research : the journal of laboratory and clinical medicine.

[17]  J. Cruz,et al.  Adipokines, diabetes and atherosclerosis: an inflammatory association , 2015, Front. Physiol..

[18]  A. Gastaldelli,et al.  The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis , 2015, Nutrients.

[19]  Sungha Park,et al.  Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. , 2015, Atherosclerosis.

[20]  Y. So,et al.  Effect of the low- versus high-intensity exercise training on endoplasmic reticulum stress and GLP-1 in adolescents with type 2 diabetes mellitus , 2015, Journal of physical therapy science.

[21]  Michael E. Hall,et al.  Lean heart: Role of leptin in cardiac hypertrophy and metabolism. , 2015, World journal of cardiology.

[22]  L. Schomburg,et al.  Chronic Kidney Disease Distinctly Affects Relationship Between Selenoprotein P Status and Serum Thyroid Hormone Parameters. , 2015, Thyroid : official journal of the American Thyroid Association.

[23]  J. Steinacker,et al.  Chronic Exercise Training and Circulating Irisin in Adults: A Meta-Analysis , 2015, Sports Medicine.

[24]  E. Elvevoll,et al.  ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary Relevance , 2015, International journal of molecular sciences.

[25]  T. Pischon,et al.  Association between dietary factors and plasma fetuin-A concentrations in the general population , 2015, British Journal of Nutrition.

[26]  Joseph Beyene,et al.  Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies , 2015, BMJ : British Medical Journal.

[27]  R. Burk,et al.  Regulation of Selenium Metabolism and Transport. , 2015, Annual review of nutrition.

[28]  P. Newsholme,et al.  Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction , 2015, Oxidative medicine and cellular longevity.

[29]  J. Krakoff,et al.  Increased 24-hour ad libitum food intake is associated with lower plasma irisin concentrations the following morning in adult humans , 2015, Appetite.

[30]  Li Chen,et al.  Mechanisms Linking Inflammation to Insulin Resistance , 2015, International journal of endocrinology.

[31]  N. Kobyliak,et al.  Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients , 2015, Journal of Diabetes & Metabolic Disorders.

[32]  Xiaoming Fan,et al.  Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease. , 2015, World journal of gastroenterology.

[33]  S. Caprio,et al.  Blunted suppression of acyl‐ghrelin in response to fructose ingestion in obese adolescents: The role of insulin resistance , 2015, Obesity.

[34]  J. Holst,et al.  Incretin effect after oral amino acid ingestion in humans. , 2015, The Journal of clinical endocrinology and metabolism.

[35]  J. Holst,et al.  The effects of TNF-α on GLP-1-stimulated plasma glucose kinetics. , 2015, The Journal of clinical endocrinology and metabolism.

[36]  J. Borén,et al.  Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease , 2015, Hepatology.

[37]  A. Tall,et al.  Cholesterol, inflammation and innate immunity , 2015, Nature Reviews Immunology.

[38]  P. Dandona,et al.  Decreased insulin secretion and incretin concentrations and increased glucagon concentrations after a high-fat meal when compared with a high-fruit and -fiber meal. , 2015, American journal of physiology. Endocrinology and metabolism.

[39]  H. Randeva,et al.  Differential Effects of Leptin and Adiponectin in Endothelial Angiogenesis , 2015, Journal of diabetes research.

[40]  P. Hoffmann,et al.  Selenoproteins and cardiovascular stress , 2014, Thrombosis and Haemostasis.

[41]  Maria F. Vasiloglou,et al.  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis , 2015, Diabetologia.

[42]  I. Ranchal,et al.  Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance , 2014, International journal of molecular sciences.

[43]  S. Legrand-Poels,et al.  Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes. , 2014, Biochemical pharmacology.

[44]  A. Jehle,et al.  Free Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes , 2014, Front. Endocrinol..

[45]  D. Umpierre,et al.  Effect of dietary lipids on circulating adiponectin: a systematic review with meta-analysis of randomised controlled trials , 2014, British Journal of Nutrition.

[46]  L. Azadbakht,et al.  Dietary intakes and leptin concentrations , 2014, ARYA atherosclerosis.

[47]  S. Fava.  Glucagon-like peptide 1 and the cardiovascular system. , 2014, Current diabetes reviews.

[48]  C. Costagliola,et al.  New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases , 2014, BioMed research international.

[49]  L. N. Valenti,et al.  Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin‐A independently of insulin resistance , 2014, European Journal of Clinical Investigation.

[50]  A. Fornoni,et al.  Lipid biology of the podocyte—new perspectives offer new opportunities , 2014, Nature Reviews Nephrology.

[51]  Jamey D. Young,et al.  Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells[S] , 2014, Journal of Lipid Research.

[52]  Maria F. Vasiloglou,et al.  Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition. , 2014, The Journal of clinical endocrinology and metabolism.

[53]  J. Holst,et al.  Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals , 2014, Diabetologia.

[54]  B. Franklin,et al.  Impact of diet and exercise on lipid management in the modern era. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[55]  M. Zhang,et al.  Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials , 2014, PloS one.

[56]  N. Filigheddu,et al.  Ghrelin Gene Products in Acute and Chronic Inflammation , 2014, Archivum Immunologiae et Therapiae Experimentalis.

[57]  M. Fasshauer,et al.  Serum levels of the myokine irisin in relation to metabolic and renal function. , 2014, European journal of endocrinology.

[58]  Amaia Rodríguez.  Novel Molecular Aspects of Ghrelin and Leptin in the Control of Adipobiology and the Cardiovascular System , 2014, Obesity Facts.

[59]  C. Mantzoros,et al.  Irisin in patients with nonalcoholic fatty liver disease. , 2014, Metabolism: clinical and experimental.

[60]  I. Laher,et al.  Exercise Induced Adipokine Changes and the Metabolic Syndrome , 2014, Journal of diabetes research.

[61]  J. Holst.  Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. , 2013, Current opinion in pharmacology.

[62]  S. Kaneko,et al.  Metformin Suppresses Expression of the Selenoprotein P Gene via an AMP-activated Kinase (AMPK)/FoxO3a Pathway in H4IIEC3 Hepatocytes* , 2013, The Journal of Biological Chemistry.

[63]  Steven Mann,et al.  Differential Effects of Aerobic Exercise, Resistance Training and Combined Exercise Modalities on Cholesterol and the Lipid Profile: Review, Synthesis and Recommendations , 2013, Sports Medicine.

[64]  J. Rutledge,et al.  Inflammasome-Mediated Secretion of IL-1β in Human Monocytes through TLR2 Activation; Modulation by Dietary Fatty Acids , 2013, The Journal of Immunology.

[65]  C. Flask,et al.  Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. , 2013, Journal of applied physiology.

[66]  Zheng Chen,et al.  Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. , 2013, Journal of hepatology.

[67]  B. Carlson,et al.  Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis , 2013, Journal of Nutritional Science.

[68]  A. Jaeschke,et al.  MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet. , 2013, American journal of physiology. Endocrinology and metabolism.

[69]  S. Tufik,et al.  The effect of weight loss magnitude on pro‐/anti‐inflammatory adipokines and carotid intima–media thickness in obese adolescents engaged in interdisciplinary weight loss therapy , 2013, Clinical endocrinology.

[70]  D. Drucker,et al.  Pharmacology, physiology, and mechanisms of incretin hormone action. , 2013, Cell metabolism.

[71]  J. Eckel,et al.  Adipo-Myokines: Two Sides of the Same Coin—Mediators of Inflammation and Mediators of Exercise , 2013, Mediators of inflammation.

[72]  Chao-Yung Wang,et al.  Decrease in Irisin in Patients with Chronic Kidney Disease , 2013, PloS one.

[73]  J. Isgaard.  Ghrelin and the cardiovascular system. , 2013, Endocrine development.

[74]  A. Grefhorst,et al.  Des‐acyl ghrelin analogs prevent high‐fat‐diet‐induced dysregulation of glucose homeostasis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  N. Gretz,et al.  CARDIOVASCULAR , PULMONARY , AND RENAL PATHOLOGY Lipid Droplet Accumulation Is Associated with an Increase in Hyperglycemia-Induced Renal Damage Prevention by Liver X Receptors , 2013 .

[76]  H. J. Yoo,et al.  Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease , 2013, Diabetes & metabolism journal.

[77]  R. Mak,et al.  Ghrelin and leptin pathophysiology in chronic kidney disease , 2013, Pediatric Nephrology.

[78]  M. Pirmohamed,et al.  Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists , 2012, PloS one.

[79]  H. Ou,et al.  Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. , 2012, The Journal of clinical endocrinology and metabolism.

[80]  A. Sanyal,et al.  Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. , 2012, Cell metabolism.

[81]  R. Alfenas,et al.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.

[82]  R. P. Ross,et al.  Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids , 2012, Journal of nutrition and metabolism.

[83]  S. Kaneko,et al.  Inverse Correlation between Serum Levels of Selenoprotein P and Adiponectin in Patients with Type 2 Diabetes , 2012, PloS one.

[84]  P. Hoffmann,et al.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. , 2012, Antioxidants & redox signaling.

[85]  P. Dandona,et al.  Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[86]  M. Tschöp,et al.  Ghrelin acylation and metabolic control , 2011, Peptides.

[87]  J. Moreno-Navarrete,et al.  Circulating glucagon is associated with inflammatory mediators in metabolically compromised subjects. , 2011, European journal of endocrinology.

[88]  N. Ahmadi,et al.  Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. , 2011, The American journal of medicine.

[89]  H. J. Yoo,et al.  Effects of a three‐month combined exercise programme on fibroblast growth factor 21 and fetuin‐A levels and arterial stiffness in obese women , 2011, Clinical endocrinology.

[90]  M. Vivarelli,et al.  Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[91]  H. J. Yoo,et al.  Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. , 2011, The Journal of clinical endocrinology and metabolism.

[92]  S. Ehrlich,et al.  Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. , 2011, Journal of psychiatric research.

[93]  A. Nakashima,et al.  Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. , 2011, Kidney international.

[94]  Michalis D. Mantzaris,et al.  Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid‐induced lipotoxicity in liver cells , 2011, The FEBS journal.

[95]  O. McGuinness,et al.  Metabolic response to endotoxin in vivo in the conscious mouse: role of interleukin-6. , 2011, Metabolism: clinical and experimental.

[96]  J. Stokes,et al.  Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes. , 2011, American journal of physiology. Endocrinology and metabolism.

[97]  S. Miyamoto,et al.  Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes , 2011, Diabetologia.

[98]  N. Chalasani,et al.  Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series , 2010, The American Journal of Gastroenterology.

[99]  M. Honda,et al.  A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.

[100]  E. Ulukaya,et al.  Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis , 2010, Annals of clinical biochemistry.

[101]  J. Hardies,et al.  Pioglitazone in the treatment of NASH: the role of adiponectin , 2010, Alimentary pharmacology & therapeutics.

[102]  L. Adorini,et al.  Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model , 2010, Diabetes.

[103]  C. Cohen,et al.  Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. , 2010, American journal of physiology. Renal physiology.

[104]  T. Hirano,et al.  Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir , 2010, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[105]  R. Büscher,et al.  Alterations in appetite-regulating hormones influence protein–energy wasting in pediatric patients with chronic kidney disease , 2010, Pediatric Nephrology.

[106]  F. Nuttall,et al.  The effect on glucagon, glucagon-like peptide-1, total and acyl-ghrelin of dietary fats ingested with and without potato. , 2010, The Journal of clinical endocrinology and metabolism.

[107]  D. Muoio,et al.  Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption , 2010, Diabetes.

[108]  G. Werstuck,et al.  Diabetes, hyperglycemia and accelerated atherosclerosis: evidence supporting a role for endoplasmic reticulum (ER) stress signaling. , 2010, Cardiovascular & hematological disorders drug targets.

[109]  B. Gualano,et al.  Low and moderate, rather than high intensity strength exercise induces benefit regarding plasma lipid profile , 2010, Diabetology & metabolic syndrome.

[110]  F. Anania,et al.  Glucagon‐like peptide‐1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway , 2010, Hepatology.

[111]  H. Dumon,et al.  Postprandial response of plasma insulin, amylin and acylated ghrelin to various test meals in lean and obese cats , 2010, British Journal of Nutrition.

[112]  R. Kawamori,et al.  Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 , 2010, Diabetes.

[113]  G. Cerasola,et al.  Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease. , 2010, Journal of nephrology.

[114]  D. Matthews,et al.  Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue , 2009, Diabetes, obesity & metabolism.

[115]  J. Tavaré,et al.  Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. , 2009, Nephrology, Dialysis and Transplantation.

[116]  D. Langin,et al.  Lipolysis and lipid mobilization in human adipose tissue. , 2009, Progress in lipid research.

[117]  Jacek Bielawski,et al.  Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. , 2009, American journal of physiology. Endocrinology and metabolism.

[118]  B. S. Mohammed,et al.  Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.

[119]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[120]  P. Havel,et al.  Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. , 2008, Metabolic syndrome and related disorders.

[121]  M. Thorner,et al.  Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. , 2008, The Journal of clinical endocrinology and metabolism.

[122]  B. Falkner,et al.  Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.

[123]  G. Fantuzzi.  Adiponectin and inflammation: consensus and controversy. , 2008, The Journal of allergy and clinical immunology.

[124]  D. Klonoff,et al.  Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. , 2008, Current medical research and opinion.

[125]  K. Kario,et al.  Differential Impacts of Adiponectin on Low‐Grade Albuminuria Between Obese and Nonobese Persons Without Diabetes , 2007, Journal of clinical hypertension.

[126]  Michelle M Wiest,et al.  A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.

[127]  S. Kihara,et al.  Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[128]  Amalia Gastaldelli,et al.  Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. , 2007, Gastroenterology.

[129]  S. McCall,et al.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.

[130]  Y. Sharabi,et al.  Metabolic Stress with a High Carbohydrate Diet Increases Adiponectin Levels , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[131]  D. Broom,et al.  A single session of treadmill running has no effect on plasma total ghrelin concentrations , 2007, Journal of sports sciences.

[132]  S. Barr,et al.  Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. , 2007, The Journal of clinical endocrinology and metabolism.

[133]  J. Gromada,et al.  α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains. , 2007, Endocrine reviews.

[134]  M. Horvat,et al.  Selenoprotein P in subjects exposed to mercury and other stress situations such as physical load or metal chelation treatment , 2002, Biological Trace Element Research.

[135]  R. Agarwal.  Effects of statins on renal function. , 2007, The American journal of cardiology.

[136]  T. Ogihara,et al.  Adiponectin and renal function, and implication as a risk of cardiovascular disease. , 2006, The American journal of cardiology.

[137]  M. J. Charron,et al.  Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia , 2006, Diabetologia.

[138]  Dong Wang,et al.  Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[139]  G. Boden.  Fatty acid—induced inflammation and insulin resistance in skeletal muscle and liver , 2006, Current diabetes reports.

[140]  F. Schick,et al.  α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans , 2006 .

[141]  R. Cone,et al.  Leptin and inflammation-associated cachexia in chronic kidney disease. , 2006, Kidney international.

[142]  Camillo Ricordi,et al.  The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[143]  V. Positano,et al.  Visceral fat and beta cell function in non-diabetic humans , 2005, Diabetologia.

[144]  P. Froguel,et al.  A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. , 2005, Diabetes.

[145]  R. Burk,et al.  Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. , 2005, Annual review of nutrition.

[146]  David A. Brenner,et al.  Free Cholesterol-loaded Macrophages Are an Abundant Source of Tumor Necrosis Factor-α and Interleukin-6 , 2005, Journal of Biological Chemistry.

[147]  G. Marchesini,et al.  Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. , 2005, The Journal of clinical endocrinology and metabolism.

[148]  T. Funahashi,et al.  Reciprocal Association of Plasma Adiponectin and Serum C-Reactive Protein Concentration in Haemodialysis Patients with End-Stage Kidney Disease – A Follow-Up Study , 2005, Nephron Clinical Practice.

[149]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[150]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[151]  A. Nevill,et al.  Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost. , 2005, Journal of applied physiology.

[152]  R. Schwabe,et al.  Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. , 2005, The Journal of biological chemistry.

[153]  E. Ferrannini,et al.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms , 2005, Diabetologia.

[154]  C. Lindgren,et al.  α2-Heremans–Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action , 2004, Diabetologia.

[155]  D. Chapelot,et al.  Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. , 2004, American journal of physiology. Endocrinology and metabolism.

[156]  F. Lönnqvist,et al.  Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. , 2004, Kidney international.

[157]  G. Matarese,et al.  The weight of leptin in immunity , 2004, Nature Reviews Immunology.

[158]  M. Wolzt,et al.  Acute Exercise has no Effect on Ghrelin Plasma Concentrations , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[159]  S. Novoselov,et al.  Specific Excision of the Selenocysteine tRNA[Ser]Sec (Trsp) Gene in Mouse Liver Demonstrates an Essential Role of Selenoproteins in Liver Function* , 2004, Journal of Biological Chemistry.

[160]  B. Monia,et al.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. , 2004, Diabetes.

[161]  R. Unger,et al.  Glucagon physiology and pathophysiology in the light of new advances , 1985, Diabetologia.

[162]  G. Marchesini,et al.  Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. , 2003, The Journal of clinical endocrinology and metabolism.

[163]  W. Jahnen-Dechent,et al.  Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. , 2003, The Biochemical journal.

[164]  H. Kruth,et al.  Accumulation of cholesterol in the lesions of focal segmental glomerulosclerosis , 2003, Nephrology.

[165]  R. DeFronzo,et al.  A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. , 2003, Diabetes.

[166]  R. Agarwal,et al.  Resting energy expenditure in chronic kidney disease: relationship with glomerular filtration rate. , 2003, Clinical nephrology.

[167]  J. F. Atkins,et al.  Deletion of Selenoprotein P Alters Distribution of Selenium in the Mouse* , 2003, The Journal of Biological Chemistry.

[168]  Bei B. Zhang,et al.  Glucagon and regulation of glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[169]  Robert V Farese,et al.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[170]  L. Flohé,et al.  Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. , 2003, The Biochemical journal.

[171]  G. Grunberger,et al.  Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. , 2002, Diabetes.

[172]  Y. Tamura,et al.  The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. , 2002, Diabetes.

[173]  E. Bruckert,et al.  Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. , 2002, The Journal of clinical endocrinology and metabolism.

[174]  V. Paradis,et al.  High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis , 2001, Hepatology.

[175]  J. Wilmore,et al.  Changes in blood lipids consequent to aerobic exercise training related to changes in body fatness and aerobic fitness. , 2001, Metabolism: clinical and experimental.

[176]  A. Steensberg,et al.  Exercise and interleukin-6 , 2001, Current opinion in hematology.

[177]  L. Sher,et al.  Selenium and human health , 2000, The Lancet.

[178]  E. Ferrannini,et al.  Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. , 2000, Diabetes.

[179]  F. Lönnqvist,et al.  Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. , 2000, Journal of the American Society of Nephrology : JASN.

[180]  A. Hippen.  Glucagon as a potential therapy for ketosis and fatty liver. , 2000, The Veterinary clinics of North America. Food animal practice.

[181]  G. Grunberger,et al.  α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor , 2000, Molecular and Cellular Endocrinology.

[182]  I. Dreher,et al.  The influence of the cytokines Il‐1β and INFγ on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2 , 2000 .

[183]  J. Köhrle,et al.  The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2. , 2000, BioFactors.

[184]  F. Folli,et al.  Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways , 1999, Hepatology.

[185]  D. Littlejohn,et al.  Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? , 1998, Clinical chemistry.

[186]  R. Wolfe,et al.  Regulation of glucose production during exercise at 80% of VO2peak in untrained humans. , 1997, The American journal of physiology.

[187]  A. Golay,et al.  Insulin action and non-esterified fatty acids , 1997, Proceedings of the Nutrition Society.

[188]  H. Baum,et al.  Removal of endogenous leptin from the circulation by the kidney , 1997, International Journal of Obesity.

[189]  A. Golay,et al.  Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). , 1997, The Proceedings of the Nutrition Society.

[190]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[191]  J A Romijn,et al.  Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. , 1993, The American journal of physiology.

[192]  I Kiss,et al.  Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. , 1991, The American journal of physiology.

[193]  E. Ravussin,et al.  Skeletal muscle metabolism is a major determinant of resting energy expenditure. , 1990, The Journal of clinical investigation.

[194]  R. Burk,et al.  Dietary selenium intake controls rat plasma selenoprotein P concentration. , 1989, The Journal of nutrition.

[195]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[196]  A. Keys.  Coronary heart disease, serum cholesterol, and the diet. , 2009, Acta medica Scandinavica.

[197]  B. J. Murawaski.  Dialysis patients. , 1980, Psychosomatic medicine.

[198]  J. Palmer,et al.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. , 1976, The Journal of clinical investigation.

[199]  D. M. Rocha,et al.  Glucagon-stimulating activity of 20 amino acids in dogs. , 1972, The Journal of clinical investigation.

[200]  R. Unger,et al.  Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. , 1968, The Journal of clinical investigation.

[201]  E. N. Allott,et al.  UREMIA , 1963 .